Botanical species · safety record

Serenoa repens

The EFSA Compendium of Botanicals holds 3 adverse-effect records for Serenoa repens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Serenoa repens (W.Bartram) Small

0Constituent measurements

3Safety records

2Cited sources

1,322Licensed products (Canada)

Also recorded as

Sabal serrulata (Michx.) Schult.f.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1,322 licensed products naming Serenoa repens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh
solid

Source material stated

Berries
Berry
Berry extract
Berry/Berries
Dried fruit
Freeze-dried berry
Freeze-dried fruit
Fruit

What the records describe

Effect types

Target tissues

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Neurotoxicity	Neurologic	—	—	Human (as organism)	Other	No resolvable identifier
Pulmonary and cardiac	Heart	—	—	Human (as organism)	Other	No resolvable identifier
Not stated	Blood coagulation	—	—	Human (as organism)	Other	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Jacobsson, Ingela., Joensson, Anna K., Gerden, Barbro., Haegg, Staffan. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden. Pharmacoepidemiology and drug safety, 2009, vol. 18, no. 11, p. 1039-1047.
Ernst, E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava . Annals of internal medicine, 2002, vol. 136, no. 1, p. 42-53.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature